Clinical trials

  • CAPECITABINE for Stage III colorectal cancer
  • TRASTUZUMAB, PERTUZUMAB for HER2-positive early breast cancer
  • IVABRADINE for Ischemic heart disease
  • INEBILIZUMAB for Immunoglobulin G4-related disease
  • TRANSPOCART19 for acute lymphoblastic leukemia (CD19+) | refractory or resistant acute lymphoblastic leukemia
  • ORX750 for Narcolepsy | Idiopathic hypersomnia
  • CABERGOLINE for Episodic migraine | Migraine
  • HUMAN ALPHA1-PROTEINASE INHIBITOR for Alpha-1 antitrypsin deficiency
  • TACROLIMUS MONOHYDRATE for Vernal Keratoconjunctivitis (VKC)
  • BEVACIZUMAB for Non-small cell lung cancer | Interstitial lung disease
  • CLN-978 for Sjögren's syndrome
  • FRUQUINTINIB for Metastatic oesophagogastric adenocarcinoma